USA - NASDAQ:PULM - US74584P3010 - Common Stock
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.00K | 7.81M | 7.30M | 6.07M | 5.17M | |||
| Operating Expenses | 6.22M | 14.95M | 22.04M | 25.02M | 21.76M | |||
| Research and Development | 47.00K | 7.17M | 15.52M | 18.24M | 15.38M | |||
| Selling, General, and Administrative Expenses | 6.17M | 7.79M | 6.52M | 6.78M | 6.38M | |||
| Operating Income | -6.21M | -7.14M | -14.74M | -18.95M | -16.59M | |||
| Interest Income/Expense | 197.00K | 400.00K | 867.00K | 310.00K | 10.00K | |||
| Other Income/Expense | -204.00K | -196.00K | -248.00K | -200.00K | -10.00K | |||
| Non Recurring Items | N/A | -2.62M | N/A | 0.00 | -3.58M | |||
| Income Before Taxes | -6.22M | -9.56M | -14.12M | -18.84M | -20.17M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -6.22M | -9.56M | -14.12M | -18.84M | -23.37M | |||
| EBITDA | N/A | -7.04M | -14.61M | -18.79M | -16.42M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.70 | -2.62 | -3.87 | -5.46 | -8.63 | |||
| Non GAAP EPS | N/A | N/A | -3.86 | -5.46 | -8.63 | |||
| Statistics | ||||||||
| Profit Margin | -207333.33% | -122.46% | -193.49% | -310.38% | -452.03% | |||
| Operating Profit Margin | -207100.00% | -91.53% | -201.97% | -312.19% | -320.89% | |||
All data in USD